1.0NOK
45.64 MNOK
438.33 MNOK
19.57 M
About VISTIN PHARMA ASA
Sector
CEO
Magnus Tolleshaug
Headquarters
Oslo
Website
Founded
2015
ISIN
NO0010734122
FIGI
BBG00N0NQX07
Vistin Pharma ASA engages in the manufacture and sale of metformin products. It offers Metformin HCI and Metformin DC. It operates through the following segments: Pharmaceuticals, Energy Trading, and Headquarter and Other. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VISTN is 23.5 NOK — it has decreased by 3.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange VISTIN PHARMA ASA stocks are traded under the ticker VISTN.
VISTIN PHARMA ASA is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
VISTN stock is 5.65% volatile and has beta coefficient of 0.52. Check out the list of the most volatile stocks — is VISTIN PHARMA ASA there?
Yes, you can track VISTIN PHARMA ASA financials in yearly and quarterly reports right on TradingView.
VISTN stock has fallen by 2.08% compared to the previous week, the month change is a 6.33% rise, over the last year VISTIN PHARMA ASA has showed a 17.50% increase.
VISTN net income for the last quarter is 18.03 M NOK, while the quarter before that showed 23.49 M NOK of net income which accounts for −23.24% change. Track more VISTIN PHARMA ASA financial stats to get the full picture.
Today VISTIN PHARMA ASA has the market capitalization of 1.08 B, it has increased by 1.26% over the last week.
Like other stocks, VISTN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VISTIN PHARMA ASA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VISTIN PHARMA ASA technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VISTIN PHARMA ASA stock shows the strong buy signal. See more of VISTIN PHARMA ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VISTIN PHARMA ASA EBITDA is 85.94 M NOK, and current EBITDA margin is 19.61%. See more stats in VISTIN PHARMA ASA financial statements.